IN-SILICO EVALUATION OF TETRAMETHYL-PYRAZINE: TREATING RECURRING SEIZURES

  • PREETI YADAV Research Scholar, Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • RAHUL KAUSHIK Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • RAJAN KURMI Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • VIKAS SHARMA Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • SANKET SHARMA Research Scholar, Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • TANNU YADAV Research Scholar, Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India
  • DIKSHA MISHRA Research Scholar, Metro College of Health Sciences and Research, Greater Noida, Uttar Pradesh, India

Abstract

Epilepsy, a chronic neurological disorder characterized by recurrent seizures, remains a challenging condition to treat due to the limited availability of potent and safe molecules. This study explores Tetramethyl-pyrazine (TMP) as a potential scaffold for epilepsy treatment, leveraging its diverse pharmacological properties. Utilizing structure-based virtual screening, we identified 300 active ligands from a virtual chemical library of 4427 compounds, narrowing down to the top 7 potential ligands for GABA-AT inhibitor properties based on binding energy, drug-likeness, non-covalent interactions, and toxicity. Our results revealed a compound (PubChem ID 227746) with high binding affinity to protein 4MS4, strong interactions within the active site, and favorable pharmacokinetic and toxicological properties, suggesting TMPz holds promise as an anti-epileptic agent.

Keywords: Epilepsy, Tetramethyl-pyrazine (TMP), Virtual Screening, GABA-AT Inhibitors, Antiepileptic Agents

Downloads

Download data is not yet available.
Statistics
60 Views | 27 Downloads
How to Cite
YADAV, P., R. KAUSHIK, R. KURMI, V. SHARMA, S. SHARMA, T. YADAV, and D. MISHRA. “IN-SILICO EVALUATION OF TETRAMETHYL-PYRAZINE: TREATING RECURRING SEIZURES”. Journal of Applied Pharmaceutical Sciences and Research, Vol. 8, no. 01, May 2025, pp. 43-51, doi:10.31069/japsr.v8i1.06.
Section
Research Articles